Srdjan R. Stankovic
2021
Compensation breakdown
| Non-Equity Incentive Plan | $149,008 |
|---|---|
| Option Awards | $1,979,073 |
| Salary | $739,377 |
| Stock Awards | $1,957,468 |
| Other | $44,711 |
| Total | $4,869,637 |
Stankovic received $2M in option awards, accounting for 41% of the total pay in 2021.
Stankovic also received $149K in non-equity incentive plan, $739.4K in salary, $2M in stock awards and $44.7K in other compensation.
Rankings
In 2021, Srdjan R. Stankovic's compensation ranked 2,705th out of 12,415 executives tracked by ExecPay. In other words, Stankovic earned more than 78.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,705 out of 12,415 | 78th |
Division Manufacturing | 1,067 out of 5,505 | 81st |
Major group Chemicals And Allied Products | 418 out of 2,375 | 82nd |
Industry group Drugs | 365 out of 2,096 | 83rd |
Industry Pharmaceutical Preparations | 241 out of 1,546 | 84th |
Pay ratio
| Srdjan R. Stankovic's Pay | $4,869,637 |
|---|---|
| Median Employee's Pay | $219,387 |
| Pay Ratio | 22to 1 |
In 2021, the annual total compensation of Srdjan R. Stankovic was $4,869,637.
The annual total compensation of the median employee at ACADIA Pharmaceuticals was $219,387.
The ratio of Srdjan R. Stankovic's pay to the pay of median employee was therefore 22 to one.
Stankovic's colleagues
We found five more compensation records of executives who worked with Srdjan R. Stankovic at ACADIA Pharmaceuticals in 2021.
2021
Stephen Davis
ACADIA Pharmaceuticals
Chief Executive Officer
2021
Mark Schneyer
ACADIA Pharmaceuticals
Chief Financial Officer
2021
Brendan Teehan
ACADIA Pharmaceuticals
Chief Operating Officer
2021
Elena Ridloff
ACADIA Pharmaceuticals
Chief Financial Officer
2021
Austin Kim
ACADIA Pharmaceuticals